Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Herpes Simplex Virus Type 1 Us3 Gene Deletion Influences Toll-like Receptor Responses in Cultured Monocytic Cells

Authors: Piritta Peri, Riikka K Mattila, Helena Kantola, Eeva Broberg, Heidi S Karttunen, Matti Waris, Tytti Vuorinen, Veijo Hukkanen

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

Toll-like receptors have a key role in innate immune response to microbial infection. The toll-like receptor (TLR) family consists of ten identified human TLRs, of which TLR2 and TLR9 have been shown to initiate innate responses to herpes simplex virus type 1 (HSV-1) and TLR3 has been shown to be involved in defence against severe HSV-1 infections of the central nervous system. However, no significant activation of the TLR3 pathways has been observed in wild type HSV-1 infections. In this work, we have studied the TLR responses and effects on TLR gene expression by HSV-1 with Us3 and ICP4 gene deletions, which also subject infected cells to apoptosis in human monocytic (U937) cell cultures.

Results

U937 human monocytic cells were infected with the Us3 and ICP4 deletion herpes simplex virus (d120), its parental virus HSV-1 (KOS), the Us3 deletion virus (R7041), its rescue virus (R7306) or wild type HSV-1 (F). The mRNA expression of TLR2, TLR3, TLR4, TLR9 and type I interferons (IFN) were analyzed by quantitative real-time PCR. The intracellular expression of TLR3 and type I IFN inducible myxovirus resistance protein A (MxA) protein as well as the level of apoptosis were analyzed by flow cytometry. We observed that the mRNA expression of TLR3 and type I IFNs were significantly increased in d120, R7041 and HSV-1 (F)-infected U937 cells. Moreover, the intracellular expression of TLR3 and MxA were significantly increased in d120 and R7041-infected cells. We observed activation of IRF-3 in infections with d120 and R7041. The TLR4 mRNA expression level was significantly decreased in d120 and R7041-infected cells but increased in HSV-1 (KOS)-infected cells in comparison with uninfected cells. No significant difference in TLR2 or TLR9 mRNA expression levels was seen. Both the R7041 and d120 viruses were able to induce apoptosis in U937 cell cultures.

Conclusion

The levels of TLR3 and type I IFN mRNA were increased in d120, R7041 and HSV-1 (F)-infected cells when compared with uninfected cells. Also IRF-3 was activated in cells infected with the Us3 gene deletion viruses d120 and R7041. This is consistent with activation of TLR3 signaling in the cells. The intracellular TLR3 and type I IFN inducible MxA protein levels were increased in d120 and R7041-infected cells but not in cells infected with the corresponding parental or rescue viruses, suggesting that the HSV-1 Us3 gene is involved in control of TLR3 responses in U937 cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005, 17: 1-14. 10.1093/intimm/dxh186CrossRefPubMed Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005, 17: 1-14. 10.1093/intimm/dxh186CrossRefPubMed
2.
go back to reference Kaisho T, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 2006, 117: 979-987. quiz 988 10.1016/j.jaci.2006.02.023CrossRefPubMed Kaisho T, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 2006, 117: 979-987. quiz 988 10.1016/j.jaci.2006.02.023CrossRefPubMed
3.
go back to reference Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004, 4: 499-511. 10.1038/nri1391CrossRefPubMed Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004, 4: 499-511. 10.1038/nri1391CrossRefPubMed
4.
go back to reference Hemmi H, Kaisho T, Takeda K, Akira S: The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003, 170: 3059-3064.CrossRefPubMed Hemmi H, Kaisho T, Takeda K, Akira S: The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 2003, 170: 3059-3064.CrossRefPubMed
5.
go back to reference Roizman B, Knipe DM, Whitley RJ: Herpes simplex viruses. In Fields Virology. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2007:2501-2601. Roizman B, Knipe DM, Whitley RJ: Herpes simplex viruses. In Fields Virology. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2007:2501-2601.
6.
go back to reference He B, Gross M, Roizman B: The g134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1997, 94: 843-848. 10.1073/pnas.94.3.843PubMedCentralCrossRefPubMed He B, Gross M, Roizman B: The g134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1997, 94: 843-848. 10.1073/pnas.94.3.843PubMedCentralCrossRefPubMed
7.
go back to reference Roizman B, Pellett PE: The Family Herpesviridae: A brief introduction. In Fields Virology. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2001:2381-2397. Roizman B, Pellett PE: The Family Herpesviridae: A brief introduction. In Fields Virology. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2001:2381-2397.
8.
go back to reference Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D: Herpes simplex virus turns off TAP to evade host immunity. Nature 1995, 375: 411-415. 10.1038/375411a0CrossRefPubMed Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D: Herpes simplex virus turns off TAP to evade host immunity. Nature 1995, 375: 411-415. 10.1038/375411a0CrossRefPubMed
9.
go back to reference Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375: 415-418. 10.1038/375415a0CrossRefPubMed Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375: 415-418. 10.1038/375415a0CrossRefPubMed
10.
go back to reference Koyama AH, Adachi A: Induction of apoptosis by herpes simplex virus type 1. J Gen Virol 1997,78(Pt 11):2909-2912.CrossRefPubMed Koyama AH, Adachi A: Induction of apoptosis by herpes simplex virus type 1. J Gen Virol 1997,78(Pt 11):2909-2912.CrossRefPubMed
11.
go back to reference Aubert M, Blaho JA: The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol 1999, 73: 2803-2813.PubMedCentralPubMed Aubert M, Blaho JA: The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol 1999, 73: 2803-2813.PubMedCentralPubMed
12.
go back to reference Leopardi R, Van Sant C, Roizman B: The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci USA 1997, 94: 7891-7896. 10.1073/pnas.94.15.7891PubMedCentralCrossRefPubMed Leopardi R, Van Sant C, Roizman B: The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci USA 1997, 94: 7891-7896. 10.1073/pnas.94.15.7891PubMedCentralCrossRefPubMed
13.
go back to reference Leopardi R, Roizman B: The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci USA 1996, 93: 9583-9587. 10.1073/pnas.93.18.9583PubMedCentralCrossRefPubMed Leopardi R, Roizman B: The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci USA 1996, 93: 9583-9587. 10.1073/pnas.93.18.9583PubMedCentralCrossRefPubMed
14.
go back to reference Galvan V, Roizman B: Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci USA 1998, 95: 3931-3936. 10.1073/pnas.95.7.3931PubMedCentralCrossRefPubMed Galvan V, Roizman B: Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc Natl Acad Sci USA 1998, 95: 3931-3936. 10.1073/pnas.95.7.3931PubMedCentralCrossRefPubMed
15.
go back to reference Zhou G, Galvan V, Campadelli-Fiume G, Roizman B: Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol 2000, 74: 11782-11791. 10.1128/JVI.74.24.11782-11791.2000PubMedCentralCrossRefPubMed Zhou G, Galvan V, Campadelli-Fiume G, Roizman B: Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol 2000, 74: 11782-11791. 10.1128/JVI.74.24.11782-11791.2000PubMedCentralCrossRefPubMed
16.
go back to reference Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101: 1315-1320. 10.1073/pnas.0308057100PubMedCentralCrossRefPubMed Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004, 101: 1315-1320. 10.1073/pnas.0308057100PubMedCentralCrossRefPubMed
17.
go back to reference Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004, 101: 11416-11421. 10.1073/pnas.0403555101PubMedCentralCrossRefPubMed Hochrein H, Schlatter B, O'Keeffe M, Wagner C, Schmitz F, Schiemann M, Bauer S, Suter M, Wagner H: Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 2004, 101: 11416-11421. 10.1073/pnas.0403555101PubMedCentralCrossRefPubMed
18.
go back to reference Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM, Colonna M: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004, 21: 107-119. 10.1016/j.immuni.2004.06.007CrossRefPubMed Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM, Colonna M: TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004, 21: 107-119. 10.1016/j.immuni.2004.06.007CrossRefPubMed
19.
go back to reference Sato A, Linehan M, Iwasaki A: Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 2006, 103: 17343-17348. 10.1073/pnas.0605102103PubMedCentralCrossRefPubMed Sato A, Linehan M, Iwasaki A: Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci USA 2006, 103: 17343-17348. 10.1073/pnas.0605102103PubMedCentralCrossRefPubMed
20.
go back to reference Zhang S, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al.: TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317: 1522-1527. 10.1126/science.1139522CrossRefPubMed Zhang S, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al.: TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007, 317: 1522-1527. 10.1126/science.1139522CrossRefPubMed
21.
go back to reference Peri P, Ilvonen H, Broberg E, Waris M, Vuorinen T, Hukkanen V: Herpes simplex virus type 1 infection interferes with toll-like receptor signaling in cultured monocytic cells. 30th International Herpesvirus Workshop; July30-August 4, 2005; Turku, Finland 2005. Abstract 9.6 Peri P, Ilvonen H, Broberg E, Waris M, Vuorinen T, Hukkanen V: Herpes simplex virus type 1 infection interferes with toll-like receptor signaling in cultured monocytic cells. 30th International Herpesvirus Workshop; July30-August 4, 2005; Turku, Finland 2005. Abstract 9.6
22.
go back to reference Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe D: Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc Natl Acad Sci USA 2008, 105: 11335-11339. 10.1073/pnas.0801617105PubMedCentralCrossRefPubMed Liu X, Fitzgerald K, Kurt-Jones E, Finberg R, Knipe D: Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein. Proc Natl Acad Sci USA 2008, 105: 11335-11339. 10.1073/pnas.0801617105PubMedCentralCrossRefPubMed
23.
go back to reference Upton J, Kaiser W, Mocarski E: Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 2008, 283: 16966-16970. 10.1074/jbc.C800051200PubMedCentralCrossRefPubMed Upton J, Kaiser W, Mocarski E: Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 2008, 283: 16966-16970. 10.1074/jbc.C800051200PubMedCentralCrossRefPubMed
24.
go back to reference Vercammen E, Staal J, Beyaert R: Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 2008, 21: 13-25. 10.1128/CMR.00022-07PubMedCentralCrossRefPubMed Vercammen E, Staal J, Beyaert R: Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev 2008, 21: 13-25. 10.1128/CMR.00022-07PubMedCentralCrossRefPubMed
25.
go back to reference Carty M, Goodbody R, Schröder M, Stack J, Moynagh P, Bowie A: The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 2006, 7: 1074-1081. 10.1038/ni1382CrossRefPubMed Carty M, Goodbody R, Schröder M, Stack J, Moynagh P, Bowie A: The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 2006, 7: 1074-1081. 10.1038/ni1382CrossRefPubMed
26.
go back to reference Bowie A, Kiss-Toth E, Symons J, Smith G, Dower S, O'Neill L: A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci USA 2000, 97: 10162-10167. 10.1073/pnas.160027697PubMedCentralCrossRefPubMed Bowie A, Kiss-Toth E, Symons J, Smith G, Dower S, O'Neill L: A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci USA 2000, 97: 10162-10167. 10.1073/pnas.160027697PubMedCentralCrossRefPubMed
27.
go back to reference Harte M, Haga I, Maloney G, Gray P, Reading P, Bartlett N, Smith G, Bowie A, O'Neill L: The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 2003, 197: 343-351. 10.1084/jem.20021652PubMedCentralCrossRefPubMed Harte M, Haga I, Maloney G, Gray P, Reading P, Bartlett N, Smith G, Bowie A, O'Neill L: The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 2003, 197: 343-351. 10.1084/jem.20021652PubMedCentralCrossRefPubMed
28.
go back to reference Fensterl V, Grotheer D, Berk I, Schlemminger S, Vallbracht A, Dotzauer A: Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J Virol 2005, 79: 10968-10977. 10.1128/JVI.79.17.10968-10977.2005PubMedCentralCrossRefPubMed Fensterl V, Grotheer D, Berk I, Schlemminger S, Vallbracht A, Dotzauer A: Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J Virol 2005, 79: 10968-10977. 10.1128/JVI.79.17.10968-10977.2005PubMedCentralCrossRefPubMed
29.
go back to reference Ferreon J, Ferreon A, Li K, Lemon S: Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 2005, 280: 20483-20492. 10.1074/jbc.M500422200CrossRefPubMed Ferreon J, Ferreon A, Li K, Lemon S: Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem 2005, 280: 20483-20492. 10.1074/jbc.M500422200CrossRefPubMed
30.
go back to reference Foy E, Li K, Sumpter RJ, Loo Y, Johnson C, Wang C, Fish P, Yoneyama M, Fujita T, Lemon S, Gale MJ: Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA 2005, 102: 2986-2991. 10.1073/pnas.0408707102PubMedCentralCrossRefPubMed Foy E, Li K, Sumpter RJ, Loo Y, Johnson C, Wang C, Fish P, Yoneyama M, Fujita T, Lemon S, Gale MJ: Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci USA 2005, 102: 2986-2991. 10.1073/pnas.0408707102PubMedCentralCrossRefPubMed
31.
go back to reference Sumpter RJ, Loo Y, Foy E, Li K, Yoneyama M, Fujita T, Lemon S, Gale MJ: Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005, 79: 2689-2699. 10.1128/JVI.79.5.2689-2699.2005PubMedCentralCrossRefPubMed Sumpter RJ, Loo Y, Foy E, Li K, Yoneyama M, Fujita T, Lemon S, Gale MJ: Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005, 79: 2689-2699. 10.1128/JVI.79.5.2689-2699.2005PubMedCentralCrossRefPubMed
32.
go back to reference Salaun B, Coste I, Rissoan M, Lebecque S, Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006, 176: 4894-4901.CrossRefPubMed Salaun B, Coste I, Rissoan M, Lebecque S, Renno T: TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 2006, 176: 4894-4901.CrossRefPubMed
33.
go back to reference Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 2007, 13: 4565-4574. 10.1158/1078-0432.CCR-07-0274CrossRefPubMed Salaun B, Lebecque S, Matikainen S, Rimoldi D, Romero P: Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 2007, 13: 4565-4574. 10.1158/1078-0432.CCR-07-0274CrossRefPubMed
34.
go back to reference Benetti L, Munger J, Roizman B: The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol 2003, 77: 6567-6573. 10.1128/JVI.77.11.6567-6573.2003PubMedCentralCrossRefPubMed Benetti L, Munger J, Roizman B: The herpes simplex virus 1 US3 protein kinase blocks caspase-dependent double cleavage and activation of the proapoptotic protein BAD. J Virol 2003, 77: 6567-6573. 10.1128/JVI.77.11.6567-6573.2003PubMedCentralCrossRefPubMed
35.
go back to reference Cartier A, Komai T, Masucci MG: The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad. Exp Cell Res 2003, 291: 242-250. 10.1016/S0014-4827(03)00375-6CrossRefPubMed Cartier A, Komai T, Masucci MG: The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad. Exp Cell Res 2003, 291: 242-250. 10.1016/S0014-4827(03)00375-6CrossRefPubMed
36.
go back to reference Munger J, Chee AV, Roizman B: The U(S)3 protein kinase blocks apoptosis induced by the d120 mutant of herpes simplex virus 1 at a premitochondrial stage. J Virol 2001, 75: 5491-5497. 10.1128/JVI.75.12.5491-5497.2001PubMedCentralCrossRefPubMed Munger J, Chee AV, Roizman B: The U(S)3 protein kinase blocks apoptosis induced by the d120 mutant of herpes simplex virus 1 at a premitochondrial stage. J Virol 2001, 75: 5491-5497. 10.1128/JVI.75.12.5491-5497.2001PubMedCentralCrossRefPubMed
37.
go back to reference Munger J, Roizman B: The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci USA 2001, 98: 10410-10415. 10.1073/pnas.181344498PubMedCentralCrossRefPubMed Munger J, Roizman B: The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci USA 2001, 98: 10410-10415. 10.1073/pnas.181344498PubMedCentralCrossRefPubMed
38.
go back to reference Ogg P, McDonell P, Ryckman B, Knudson C, Roller R: The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 2004, 319: 212-224. 10.1016/j.virol.2003.10.019CrossRefPubMed Ogg P, McDonell P, Ryckman B, Knudson C, Roller R: The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members. Virology 2004, 319: 212-224. 10.1016/j.virol.2003.10.019CrossRefPubMed
39.
go back to reference Poon A, Gu H, Roizman B: ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc Natl Acad Sci USA 2006, 103: 9993-9998. 10.1073/pnas.0604142103PubMedCentralCrossRefPubMed Poon A, Gu H, Roizman B: ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc Natl Acad Sci USA 2006, 103: 9993-9998. 10.1073/pnas.0604142103PubMedCentralCrossRefPubMed
40.
go back to reference Poon A, Liang Y, Roizman B: Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0. J Virol 2003, 77: 12671-12678. 10.1128/JVI.77.23.12671-12678.2003PubMedCentralCrossRefPubMed Poon A, Liang Y, Roizman B: Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0. J Virol 2003, 77: 12671-12678. 10.1128/JVI.77.23.12671-12678.2003PubMedCentralCrossRefPubMed
41.
go back to reference Takaoka A, Wang Z, Choi M, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, et al.: DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448: 501-505. 10.1038/nature06013CrossRefPubMed Takaoka A, Wang Z, Choi M, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, et al.: DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448: 501-505. 10.1038/nature06013CrossRefPubMed
42.
go back to reference Purves F, Longnecker R, Leader D, Roizman B: Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J Virol 1987, 61: 2896-2901.PubMedCentralPubMed Purves F, Longnecker R, Leader D, Roizman B: Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture. J Virol 1987, 61: 2896-2901.PubMedCentralPubMed
43.
go back to reference DeLuca N, McCarthy A, Schaffer P: Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985, 56: 558-570.PubMedCentralPubMed DeLuca N, McCarthy A, Schaffer P: Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985, 56: 558-570.PubMedCentralPubMed
44.
go back to reference Makela M, Oling V, Marttila J, Waris M, Knip M, Simell O, Ilonen J: Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes. Clin Exp Immunol 2006, 145: 261-270. 10.1111/j.1365-2249.2006.03146.xPubMedCentralCrossRefPubMed Makela M, Oling V, Marttila J, Waris M, Knip M, Simell O, Ilonen J: Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes. Clin Exp Immunol 2006, 145: 261-270. 10.1111/j.1365-2249.2006.03146.xPubMedCentralCrossRefPubMed
45.
go back to reference Broberg EK, Nygardas M, Salmi AA, Hukkanen V: Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by Light Cycler quantitative real-time PCR. Journal of Virological Methods 2003, 112: 53-65. 10.1016/S0166-0934(03)00191-5CrossRefPubMed Broberg EK, Nygardas M, Salmi AA, Hukkanen V: Low copy number detection of herpes simplex virus type 1 mRNA and mouse Th1 type cytokine mRNAs by Light Cycler quantitative real-time PCR. Journal of Virological Methods 2003, 112: 53-65. 10.1016/S0166-0934(03)00191-5CrossRefPubMed
46.
go back to reference Halminen M, Ilonen J, Julkunen I, Ruuskanen O, Simell O, Mäkelä M: Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res 1997, 41: 647-650. 10.1203/00006450-199705000-00008CrossRefPubMed Halminen M, Ilonen J, Julkunen I, Ruuskanen O, Simell O, Mäkelä M: Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res 1997, 41: 647-650. 10.1203/00006450-199705000-00008CrossRefPubMed
47.
go back to reference Ronni T, Melén K, Malygin A, Julkunen I: Control of IFN-inducible MxA gene expression in human cells. J Immunol 1993, 150: 1715-1726.PubMed Ronni T, Melén K, Malygin A, Julkunen I: Control of IFN-inducible MxA gene expression in human cells. J Immunol 1993, 150: 1715-1726.PubMed
Metadata
Title
Herpes Simplex Virus Type 1 Us3 Gene Deletion Influences Toll-like Receptor Responses in Cultured Monocytic Cells
Authors
Piritta Peri
Riikka K Mattila
Helena Kantola
Eeva Broberg
Heidi S Karttunen
Matti Waris
Tytti Vuorinen
Veijo Hukkanen
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-140

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.